1176 - 1200 of 8801 Results
Title
Year
-
RESTRICTEDTitle: Enhancing Diversity and Inclusion in Clinical TrialsJournal Name: Clinical Pharmacology & TherapeuticsPublisher: WileyVol: 113Issue #: 3Start Page: 489End Page: 499Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/cpt.2819Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.2819Citation Count: 17
-
RESTRICTEDTitle: Do CSF Biomarkers Predict Progression to Cognitive Impairment in Parkinson’s disease patients? A Systematic ReviewJournal Name: Neuropsychology ReviewPublisher: Springer Science and Business Media LLCVol: 25Issue #: 4Start Page: 411End Page: 423Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11065-015-9307-8Best OA location URL: https://europepmc.org/articles/pmc5152566?pdf=renderCitation Count: 18
-
RESTRICTEDTitle: Neuropsychiatric symptoms in untreated Parkinson’s diseaseJournal Name: Neuropsychiatric Disease and TreatmentPublisher: Informa UK LimitedVol: Volume 13Issue #:Start Page: 815End Page: 826Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.2147/ndt.s130997Best OA location URL: https://www.dovepress.com/getfile.php?fileID=35506Citation Count: 41
-
RESTRICTEDTitle: Promise of mGluR2/3 activators in psychiatryJournal Name: NeuropsychopharmacologyPublisher: Springer Science and Business Media LLCVol: 34Issue #: 1Start Page: 248End Page: 249Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/npp.2008.156Best OA location URL: https://www.nature.com/articles/npp2008156.pdfCitation Count: 37
-
RESTRICTEDTitle: Aberrant Protein S-Nitrosylation in Neurodegenerative DiseasesJournal Name: NeuronPublisher: Elsevier BVVol: 78Issue #: 4Start Page: 596End Page: 614Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.neuron.2013.05.005Best OA location URL: http://www.cell.com/article/S089662731300398X/pdfCitation Count: 305
-
RESTRICTEDTitle: Glycolysis: The Next Big Breakthrough in Parkinson’s DiseaseJournal Name: Neurotoxicity ResearchPublisher: Springer Science and Business Media LLCVol: 40Issue #: 6Start Page: 1707End Page: 1717Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s12640-022-00579-3Citation Count: 4
- Functional tremor2022RESTRICTEDTitle: Functional tremorJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 435Issue #:Start Page: 120208End Page: 120208Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.jns.2022.120208Best OA location URL: http://www.jns-journal.com/article/S0022510X22000703/pdfCitation Count: 11
-
RESTRICTEDTitle: Corrigendum to “Anti-α-synuclein ASO delivered to monoamine neurons prevents α-synuclein accumulation in a Parkinson's disease-like mouse model and in monkeys” [EBioMedicine 2020; 59:102944]Journal Name: eBioMedicinePublisher: Elsevier BVVol: 74Issue #:Start Page: 103731End Page: 103731Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.ebiom.2021.103731Best OA location URL: http://www.thelancet.com/article/S2352396421005259/pdfCitation Count: 0
-
RESTRICTEDTitle: Emerging roles of endoplasmic reticulum proteostasis in brain developmentJournal Name: Cells & DevelopmentPublisher: Elsevier BVVol: 170Issue #:Start Page: 203781End Page: 203781Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.cdev.2022.203781Best OA location URL: https://doi.org/10.1016/j.cdev.2022.203781Citation Count: 5
-
RESTRICTEDTitle: REM sleep behavior and olfactory dysfunction: Enhancing the utility and translation of animal models in the search for precision medicines for Parkinson's diseaseJournal Name: Neuroscience & Biobehavioral ReviewsPublisher: Elsevier BVVol: 143Issue #:Start Page: 104897End Page: 104897Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neubiorev.2022.104897Citation Count: 1
-
RESTRICTEDTitle: Glucose-lowering drugs, cognition, and dementia: The clinical evidenceJournal Name: Neuroscience & Biobehavioral ReviewsPublisher: Elsevier BVVol: 137Issue #:Start Page: 104654End Page: 104654Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.neubiorev.2022.104654Best OA location URL: http://manuscript.elsevier.com/S0149763422001439/pdf/S0149763422001439.pdfCitation Count: 8
-
RESTRICTEDTitle: Why do ‘OFF’ periods still occur during continuous drug delivery in Parkinson’s disease?Journal Name: Translational NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40035-022-00317-xBest OA location URL: https://translationalneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s40035-022-00317-xCitation Count: 4
-
RESTRICTEDTitle: Cognitive Syndromes Associated With Movement DisordersJournal Name: CONTINUUM: Lifelong Learning in NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 28Issue #: 3Start Page: 726End Page: 749Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/con.0000000000001134Citation Count: 1
-
RESTRICTEDTitle: Long-term Employment Outcomes After Epilepsy Surgery in ChildhoodJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 96Issue #: 20Start Page: 969End Page: 969Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000011418Best OA location URL: https://n.neurology.org/content/neurology/96/20/969.1.full.pdfCitation Count: 0
-
RESTRICTEDTitle: Tracer development for PET imaging of proteinopathiesJournal Name: Nuclear Medicine and BiologyPublisher: Elsevier BVVol: 114-115Issue #:Start Page: 115End Page: 127Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nucmedbio.2022.04.001Best OA location URL: https://doi.org/10.1016/j.nucmedbio.2022.04.001Citation Count: 3
-
RESTRICTEDTitle: The Future of Research in Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 71Issue #: 11Start Page: 1351End Page: 1351Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2014.1717Citation Count: 31
-
RESTRICTEDTitle: Motor subtype in Parkinson's disease: Different disorders or different stages of disease?Journal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 7Start Page: 957End Page: 961Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26657Citation Count: 91
- Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson’s disease2018RESTRICTEDTitle: Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson’s diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 109Issue #:Start Page: 249End Page: 257Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2017.04.004Citation Count: 514
-
RESTRICTEDTitle: The emerging role of Rab GTPases in the pathogenesis of Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 2Start Page: 196End Page: 207Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27270Best OA location URL: http://minerva-access.unimelb.edu.au/bitstreams/d21a08f5-cedc-5b9b-84f8-22c5ae15eee6/downloadCitation Count: 51
-
RESTRICTEDTitle: Disease-modifying strategies for Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 11Start Page: 1442End Page: 1450Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26354Citation Count: 192
-
RESTRICTEDTitle: Sensory aspects in myasthenia gravis: A translational approachJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 368Issue #:Start Page: 379End Page: 388Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2016.07.014Best OA location URL: http://repositorio.udes.edu.co/bitstreams/b124e51e-784c-4cf5-bff1-c42eb6dbb8fb/downloadCitation Count: 8
-
RESTRICTEDTitle: Hereditary parkinsonism: Parkinson disease look‐alikes—An algorithm for clinicians to “PARK” genes and beyondJournal Name: Movement DisordersPublisher: WileyVol: 24Issue #: 14Start Page: 2042End Page: 2058Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.22675Citation Count: 67
-
RESTRICTEDTitle: Effects of α-synuclein on axonal transportJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 105Issue #:Start Page: 321End Page: 327Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.nbd.2016.12.008Best OA location URL: http://manuscript.elsevier.com/S0969996116302893/pdf/S0969996116302893.pdfCitation Count: 52
-
RESTRICTEDTitle: The spectrum of “off” in Parkinson's disease: What have we learned over 40 years?Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 51Issue #:Start Page: 9End Page: 16Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.02.001Citation Count: 108
-
RESTRICTEDTitle: Gaucher-related synucleinopathies: The examination of sporadic neurodegeneration from a rare (disease) angleJournal Name: Progress in NeurobiologyPublisher: Elsevier BVVol: 125Issue #:Start Page: 47End Page: 62Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.pneurobio.2014.12.001Best OA location URL: https://doi.org/10.1016/j.pneurobio.2014.12.001Citation Count: 65